Compare Sana Biotechnology Inc (SANA) vs Tesla, Inc. (TSLA) Price & Performance

Sana Biotechnology IncTrade

Tesla, Inc.Trade

Price performance (Past 24H)

Key statistics

Sana Biotechnology Inc vs Tesla, Inc. — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Tesla, Inc. trades at $378.76 (market cap $1.39T). The key difference: Tesla, Inc. is far larger — about 1590.7× Sana Biotechnology Inc's market cap, and Tesla, Inc. is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

	SANA	TSLA
Market Cap	$873.84M	$1.39T
Sector	Health	Consumer Cyclical
52-Week High	$5.92	$489.88
52-Week Low	$2.68	$302.63
Enterprise Value	$848.03M	$1.36T

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sana Biotechnology Inc

SANA Biotechnology trades at $3.14, down 0.32% with a bearish technical signal. The company shows negative profitability metrics with ROE at -147.41% and net income of -$244.17M for 2025, though cash burn is projected to improve significantly in 2026. Recent positive developments include NEJM publication of groundbreaking diabetes data and multiple conference presentations highlighting clinical progress.

While analyst sentiment remains strongly bullish (82% buy ratings), the stock faces fundamental challenges with significant losses and high P/B ratio of 7.33. Investment opportunity lies in clinical pipeline advancements, but risks include ongoing cash burn and execution challenges in bringing therapies to market.

Tesla, Inc.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SANA

View details →

TSLA

Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 9 hours agoNeutral Northrop Grumman CEO hints space robots could be weaponized, leaving decision to US government.Forbes · 9 hours agoBullish Options traders expect Tesla's biggest post-earnings move in a year, with a 5.76% price swing implied.CNBC · 10 hours agoNeutral View details →

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.